We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
Cap. Flow
+$17.6M
Cap. Flow %
2.5%
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
SJM icon
J.M. Smucker
SJM
+$2.94M
2
PYPL icon
PayPal
PYPL
+$2.45M
3
NVO
Novo Nordisk
NVO
+$2.38M
4
ADI icon
Analog Devices
ADI
+$1.8M
5
ADNT icon
Adient
ADNT
+$1.65M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.63M
2
IPGP icon
IPG Photonics
IPGP
+$1.49M
3
PRGO icon
Perrigo
PRGO
+$1.24M
4
KR icon
Kroger
KR
+$1.05M
5
GILD icon
Gilead Sciences
GILD
+$990K

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Technology 19.56%
3 Industrials 16.26%
4 Consumer Staples 11.7%
5 Financials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
126
Comcast
CMCSA
$91B
$632K 0.09%
18,294
– –
ROST icon
127
Ross Stores
ROST
$80.8B
$630K 0.09%
9,604
+800
+9% +$52.3K
IWF icon
128
iShares Russell 1000 Growth ETF
IWF
$127B
$626K 0.09%
23,876
+444
+2% +$11.5K
EPD icon
129
Enterprise Products Partners
EPD
$81.8B
$622K 0.09%
22,996
+2,700
+13% +$70.3K
SPGI icon
130
S&P Global
SPGI
$120B
$613K 0.09%
5,700
– –
ACN icon
131
Accenture
ACN
$110B
$602K 0.09%
5,140
+1,450
+39% +$172K
ZTS icon
132
Zoetis
ZTS
$31.1B
$596K 0.08%
11,137
– –
JPM icon
133
JPMorgan Chase
JPM
$962B
$576K 0.08%
6,680
-365
-5% -$27.8K
SON icon
134
Sonoco
SON
$5.71B
$552K 0.08%
10,475
+2,675
+34% +$140K
KHC icon
135
Kraft Heinz
KHC
$29.2B
$543K 0.08%
6,213
-25
-0.4% -$2.14K
VNQ icon
136
Vanguard Real Estate ETF
VNQ
$38.3B
$541K 0.08%
6,551
-434
-6% -$35.3K
NOBL icon
137
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$504K 0.07%
18,700
+2,140
+13% +$57.1K
VIG icon
138
Vanguard Dividend Appreciation ETF
VIG
$114B
$502K 0.07%
5,894
+141
+2% +$11.9K
GSK icon
139
GSK
GSK
$102B
$501K 0.07%
10,407
-1,391
-12% -$68.7K
MDT icon
140
Medtronic
MDT
$116B
$501K 0.07%
7,040
+127
+2% +$9.98K
WEC icon
141
WEC Energy
WEC
$34.8B
$501K 0.07%
8,535
-150
-2% -$8.61K
MDLZ icon
142
Mondelez International
MDLZ
$78.9B
$500K 0.07%
11,279
+208
+2% +$8.96K
LLY icon
143
Eli Lilly
LLY
$1.08T
$489K 0.07%
6,654
-100
-1% -$7.45K
BDX icon
144
Becton Dickinson
BDX
$49.4B
$479K 0.07%
2,964
-436
-13% -$72.4K
NTAP icon
145
NetApp
NTAP
$38.9B
$476K 0.07%
+13,500
New +$472K
CSL icon
146
Carlisle Companies
CSL
$15.5B
$463K 0.07%
4,200
+200
+5% +$21.8K
GLW icon
147
Corning
GLW
$137B
$463K 0.07%
19,087
+2,980
+19% +$70.8K
ESRX
148
DELISTED
Express Scripts Holding Company
ESRX
$461K 0.07%
6,700
+837
+14% +$60K
PRU icon
149
Prudential Financial
PRU
$42.2B
$445K 0.06%
4,273
-4,350
-50% -$412K
SYY icon
150
Sysco
SYY
$40.3B
$426K 0.06%
7,695
– –
4 5
6
7 8

Similar funds

SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
C
Consulta London, United Kingdom $2.01B AUM 16.82% 1-Year Est. Return

Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
  • Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
  • Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
  • Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
  • Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.